Neurocrine Biosciences Resolves Patent Litigation With Lupin

By Ben Glickman Neurocrine Biosciences and Lupin resolved patent litigation related to Neurocrine's Ingrezza medication. Lupin will have the right to sell...

Related Keywords

Neurocrine Ingrezza , Neurocrine Biosciences , Ben Glickman , Teva Pharmaceuticals , Article Normal , Biotechnology Services , Pharmaceuticals , Healthcare Life Sciences , Generic Biosimilar Drugs , Patents , Corporate Industrial News , Intellectual Property Rights , Industrial Property Rights , Synd , Nbix , Teva Pharmaceutical Industries , Teva Tv , Teva , Corporate , Industrial News , Healthcare , Life Sciences , Generic , Biosimilar Drugs ,